TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury

TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury
复制标题

DOI:
10.1002/jlb.64.4.528
复制
发表时间:
1998-10-01
影响因子:
5.5
通讯作者:
Kunkel, SL
Kunkel, SL
中科院分区:
医学3区
文献类型:
--
作者:
Smith, RE;Strieter, RM;Kunkel, SL

文献摘要

被引文献

相似文献

以前,巨噬细胞炎性蛋白-1 α C-C趋化因子家族的成员MIP-1 α(MIP-1 α)与博来霉素诱导的肺纤维化(人类疾病特发性肺纤维化的模型)有关。在博来霉素攻击的CBA/J小鼠中,用抗MIP-1 α抗体中和MIP-1 α蛋白显著减弱单核吞噬细胞募集和肺纤维化。然而,在博来霉素诱导的损伤中MIP-1 α表达的特异性刺激还没有被表征。在这份报告中,两个介质的炎症反应,博莱霉素,肿瘤坏死因子(TNF)和白细胞介素-6(IL-6),被评估为假定的刺激MIP-1 α表达后,博莱霉素在CBA/J小鼠的挑战。在博来霉素激发后的时间点,在博来霉素处理的CBA/J小鼠的支气管肺泡灌洗液(BAL)液和肺匀浆中检测到生物活性TNF和IL-6水平升高,这先于MIP-1 α蛋白表达。用可溶性TNF受体(sTNFr)或抗IL-6抗体治疗博来霉素攻击的小鼠显著降低肺中MIP-1 α蛋白表达。此外,正常肺泡巨噬细胞分泌的MIP-1 α蛋白水平升高的治疗与TNF加IL-6或博莱霉素加IL-6,但不是TNF,博莱霉素,或IL-6单独。最后,当单独用TNF处理时,与对照组相比,从博来霉素攻击小鼠的BAL液中回收的白细胞分泌更高水平的MIP-1 α蛋白。基于本文提供的时间数据,我们认为TNF和IL-6是细胞因子网络的一部分,该网络调节促纤维化炎性病变中MIP-1 α蛋白表达,并对博莱霉素内给药产生反应。
Previously, macrophage inflammatory protein-1 alpha (MIP-1 alpha), a member of the C-C chemokine family, has been implicated in bleomycin-induced pulmonary fibrosis, a model of the human disease idiopathic pulmonary fibrosis, Neutralization of MIP-1 alpha protein with anti-MIP-1 alpha antibodies significantly attenuated both mononuclear phagocyte recruitment and pulmonary fibrosis in bleomycin-challenged CBA/J mice, However, the specific stimuli for MIP-1 alpha expression in the bleomycin-induced lesion have not been characterized. In this report, two mediators of the inflammatory response to bleomycin, tumor necrosis factor (TNF) and interleukin-6 (IL-6), were evaluated as putative stimuli for MIP-1 alpha expression after bleomycin challenge in CBA/J mice. Elevated levels of bioactive TNF and IL-6 were detected in bronchoalveolar lavage (BAL) fluid and lung homogenates from bleomycin-treated CBA/J mice at time points post-bleomycin challenge, which precede MIP-1 alpha protein expression. Treatment of bleomycin-challenged mice with soluble TNF receptor (sTNFr) or anti-IL-6 antibodies significantly decreased MIP-1 alpha protein expression in the lungs. Furthermore, normal alveolar macrophages secreted elevated levels of MIP-1 alpha protein in response to treatment with TNF plus IL-6 or bleomycin plus IL-6, but not TNF, bleomycin, or IL-6 alone. Finally, leukocytes recovered from the BAL fluid of bleomycin-challenged mice secreted higher levels of MIP-1 alpha protein, compared to controls, when treated with TNF alone. Based on time data presented here, we propose that TNF and IL-6 are part of a cytokine network that modulates MIP-1 alpha protein expression in the profibrotic inflammatory lesion during the response to intratracheal bleomycin challenge.